Skip to main content
Clinical Trials/NCT01203137
NCT01203137
Completed
Not Applicable

Prognostic Value of Early Postoperative Right Ventricular Systolic Function in Patients With Isolated Severe Tricuspid Regurgitation

Seoul National University Hospital1 site in 1 country60 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tricuspid Regurgitation
Sponsor
Seoul National University Hospital
Enrollment
60
Locations
1
Primary Endpoint
clinical event
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Preoperative right ventricular end-systolic area (RV-ESA) and hemoglobin level were suggested as independent prognosticator for predicting long-term prognosis in patients with isolated severe TR undergoing corrective surgery We attempted to explore whether early postoperative echocardiography provides additional prognostic information on top of preoperative clinical and echocardiographic variables.

Detailed Description

We prospectively recruited patients with isolated severe TR undergoing corrective surgery. Comprehensive preoperative echocardiography was performed in all patients, with the performance of early postoperative echocardiography in all patients. During follow-up, clinical events, defined as operative mortality (death within 30 days after surgery or before discharge), cardiovascular death, repeated open heart surgery, and readmission due to cardiovascular problems were investigated.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
February 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyung-Kwan Kim

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • severe tricuspid regurgitation

Exclusion Criteria

  • concomitant left-sided valve surgery
  • significant coronary artery disease

Outcomes

Primary Outcomes

clinical event

Time Frame: 40 months

Clinical events were defined as operative mortality (death within 30 days after surgery or before discharge), cardiovascular death, repeated open heart surgery, and readmission due to cardiovascular problems.

Study Sites (1)

Loading locations...

Similar Trials